$0.60
9.83% today
Nasdaq, Apr 04, 08:41 pm CET
ISIN
US70387R1068
Symbol
PAVM

PAVmed, Inc. Target price 2025 - Analyst rating & recommendation

PAVmed, Inc. Classifications & Recommendation:

Buy
100%

PAVmed, Inc. Price Target

Target Price $4.00
Price $0.66
Potential
Number of Estimates 1
1 Analyst has issued a PAVmed, Inc. price target 2026. The average PAVmed, Inc. target price is $4.00. This is higher than the current stock price.
A rating was issued by 1 analysts: 1 Analysts recommend PAVmed, Inc. to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the PAVmed, Inc. stock has an average upside potential 2026 of . Most analysts recommend the PAVmed, Inc. stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 3.00 0.21
22.45% 93.17%
Net Margin 186.67% -3,114.15%
104.46% 1,768.29%

1 Analyst has issued a sales forecast PAVmed, Inc. 2025 . The average PAVmed, Inc. sales estimate is

$205k
Unlock
. This is
93.17% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$205k 93.17%
Unlock
, the lowest is
$205k 93.17%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $3.0m 22.45%
2025
$205k 93.17%
Unlock
2026
$1.1m 450.24%
Unlock

1 Analyst has issued a net profit forecast PAVmed, Inc. 2025 . The average PAVmed, Inc. net profit estimate is

$-6.4m
Unlock
. This is
74.68% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-6.4m 74.68%
Unlock
, the lowest is
$-6.4m 74.68%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $5.6m 105.46%
2025
$-6.4m 213.93%
Unlock
2026
$-4.6m 28.06%
Unlock

Net Margin

2024 186.67% 104.46%
2025
-3,114.15% 1,768.29%
Unlock
2026
-407.09% 86.93%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 0.50 -0.57
105.46% 214.00%
P/E negative
EV/Sales 197.71

1 Analysts have issued a PAVmed, Inc. forecast for earnings per share. The average PAVmed, Inc. EPS is

$-0.57
Unlock
. This is
74.67% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.57 74.67%
Unlock
, the lowest is
$-0.57 74.67%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $0.50 105.46%
2025
$-0.57 214.00%
Unlock
2026
$-0.41 28.07%
Unlock

P/E ratio

Current -0.29 26.09%
2025
-1.16 300.00%
Unlock
2026
-1.61 38.79%
Unlock

Based on analysts' sales estimates for 2025, the PAVmed, Inc. stock is valued at an EV/Sales of

197.71
Unlock
and an P/S ratio of
54.05
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 13.51 59.39%
2025
197.71 1,363.41%
Unlock
2026
35.93 81.83%
Unlock

P/S ratio

Current 3.69 53.90%
2025
54.05 1,363.43%
Unlock
2026
9.82 81.83%
Unlock

Current PAVmed, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Ascendiant Capital
Locked
Locked
Locked Dec 09 2024
Ascendiant Capital
Locked
Locked
Locked Sep 10 2024
Analyst Rating Date
Locked
Ascendiant Capital:
Locked
Locked
Dec 09 2024
Locked
Ascendiant Capital:
Locked
Locked
Sep 10 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today